DENTSPLY SIRONA Inc. Expected to Post Q1 2025 Earnings of $0.53 Per Share (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Stock analysts at William Blair issued their Q1 2025 earnings per share (EPS) estimates for DENTSPLY SIRONA in a report issued on Thursday, May 2nd. William Blair analyst B. Vazquez forecasts that the medical instruments supplier will post earnings of $0.53 per share for the quarter. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $2.04 per share. William Blair also issued estimates for DENTSPLY SIRONA’s Q2 2025 earnings at $0.59 EPS, Q3 2025 earnings at $0.59 EPS, Q4 2025 earnings at $0.64 EPS and FY2025 earnings at $2.35 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.42. The company had revenue of $953.00 million during the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The company’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.39 earnings per share.

Other research analysts have also issued research reports about the stock. Robert W. Baird lowered their price objective on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a research note on Friday, May 3rd. StockNews.com downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. The Goldman Sachs Group cut their price target on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating for the company in a report on Monday. Piper Sandler reaffirmed a “neutral” rating and issued a $32.00 price objective (down previously from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. Finally, Evercore ISI cut their target price on shares of DENTSPLY SIRONA from $40.00 to $35.00 and set an “outperform” rating for the company in a research note on Friday, May 3rd. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $35.22.

DENTSPLY SIRONA Price Performance

XRAY stock opened at $28.25 on Monday. The firm’s 50-day moving average is $31.91 and its two-hundred day moving average is $32.66. The company has a market capitalization of $5.87 billion, a price-to-earnings ratio of -64.20, a price-to-earnings-growth ratio of 1.24 and a beta of 1.00. DENTSPLY SIRONA has a 52 week low of $26.27 and a 52 week high of $41.65. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several hedge funds have recently bought and sold shares of the business. Heartland Advisors Inc. increased its holdings in shares of DENTSPLY SIRONA by 94.8% in the 1st quarter. Heartland Advisors Inc. now owns 386,525 shares of the medical instruments supplier’s stock valued at $12,829,000 after purchasing an additional 188,087 shares during the period. Illinois Municipal Retirement Fund increased its stake in DENTSPLY SIRONA by 369.9% in the 1st quarter. Illinois Municipal Retirement Fund now owns 123,580 shares of the medical instruments supplier’s stock valued at $4,102,000 after buying an additional 97,281 shares during the period. SG Americas Securities LLC lifted its position in DENTSPLY SIRONA by 2,959.1% in the 1st quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier’s stock worth $45,584,000 after buying an additional 1,328,525 shares in the last quarter. Quantbot Technologies LP boosted its stake in shares of DENTSPLY SIRONA by 121.3% during the 1st quarter. Quantbot Technologies LP now owns 77,250 shares of the medical instruments supplier’s stock valued at $2,564,000 after buying an additional 42,342 shares during the period. Finally, Envestnet Portfolio Solutions Inc. grew its holdings in shares of DENTSPLY SIRONA by 6.6% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 10,748 shares of the medical instruments supplier’s stock valued at $357,000 after acquiring an additional 662 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were issued a dividend of $0.16 per share. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date was Wednesday, March 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.27%. DENTSPLY SIRONA’s payout ratio is currently -145.45%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.